title: Quinupristin-dalfopristin use in children is associated with arthralgias and myalgias.
authors.forename: Girish
authors.initials: G
authors.lastname: Gupte
authors.forename: S
authors.initials: S
authors.lastname: Jyothi
authors.forename: Sue V
authors.initials: SV
authors.lastname: Beath
authors.forename: Deidre A
authors.initials: DA
authors.lastname: Kelly
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D018771:Arthralgia / Q000139:chemically induced*; D002648:Child; D002675:Child, Preschool; D016984:Enterococcus faecium / Q000187:drug effects; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007223:Infant; D009135:Muscular Diseases / Q000139:chemically induced*; D016377:Organ Transplantation / Q000009:adverse effects*; D016896:Treatment Outcome; D020713:Vancomycin Resistance; D014769:Virginiamycin / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D014769:Virginiamycin; C062940:quinupristin-dalfopristin